ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Article
Purchase PDF (298 K)

Article Toolbox
 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/S0166-6851(98)00074-7    
How to Cite or Link Using DOI (Opens New Window)

Copyright © 1998 Elsevier Science B.V. All rights reserved

A cell cycle model for the tachyzoite of Toxoplasma gondii using the Herpes simplex virus thymidine kinase

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Jay R. Radke and Michael W. White*

Department of Veterinary Molecular Biology, Montana State University, Bozeman, MT 59717-3610, USA


Received 12 February 1998;
accepted 15 May 1998.
Available online 28 August 1998.

Abstract

Toxoplasma gondii (RH strain) tachyzoites were transfected with a plasmid containing a fusion of the chloramphenicol acetyl transferase and the Herpes simplex virus-2 thymidine kinase coding regions and transgenic parasites obtained by chloramphenicol selection. CTK11, a single high expressing clone was isolated based on immunofluorescence and contained approximately five integrated copies of the fusion sequence. Lysates prepared from this clone displayed thymidine kinase activity of 2.9 pmol min−1 μg−1 protein, whereas thymidine kinase activity was not detected in lysates from the parental RH strain. Growth of CTK11 tachyzoites was fully inhibited in 5 μM ganciclovir and thymidine and in 2.5 μM 5-bromo-2′-deoxyuridine. While the inhibitory effects of ganciclovir were lethal, low concentrations of thymidine (10 μM) were largely reversible. Asynchronously growing CTK11 tachyzoites were found to contain major G1 (1 N) and S phase (1 N+) distributions as determined by relative propidium iodide fluorescence and with reference to the haploid (1 N) DNA content of a T. gondii sporozoite population. CTK11 tachyzoites blocked 4 h in 10 μM thymidine exhibited mean fluorescence consistent with a 1 N complement of DNA indicating growth was arrested in G1. Following the removal of excess thymidine, parasites immediately entered S phase, thus confirming the late G1 block. Parasites with a 2 N complement of DNA (G2+M) first appear at 2 h post-release, while 1 N (G1) parasites re-appear at 3 h suggesting the length of S phase is ≤2 h and that of G2+M is ≤1 h. Within 7 h, parasites had transited G2+M and much of G1 and re-entered S of the subsequent cell cycle—a time consistent with the doubling of these parasites in culture. Thus, the CTK11 tachyzoite cell cycle is similar to those of higher eukaryotic cells and is characterized by major G1 and S phases and a relatively short G2+M.

Author Keywords: Coccidia; Parasite; CAT; Thymidine kinase; Positive/negative selection; Growth inhibition; BrdU; Ganciclovir; Cell cycle; G1; S; G2+M

Abbreviations: BrdU, bromo-deoxyuridine; CAT, chloramphenicol acetyl transferase; DHFR, dihydrofolate reductase; HSTK, Herpes simplex thymidine kinase; PBS, phosphate buffered saline; PI, propidium iodide

Article Outline

1. Introduction
2. Methods
2.1. Cell culture and parasite growth
2.2. Chemicals
2.3. CAT-HSTK+ plasmid construct and electroporation
2.4. Southern analysis
2.5. Thymidine kinase assay
2.6. Dose response to thymidine, BrdU and ganciclovir
2.7. Flow cytometry and cell cycle analysis
3. Results
3.1. Expression of Herpes simplex virus thymidine kinase in T. gondii tachyzoites
3.2. Thymidine, BrdU and ganciclovir inhibit the growth of CTK11 tachyzoites
3.3. Flow cytometric analysis of tachyzoite nuclear DNA content
3.4. Thymidine-arrest of CTK11 tachyzoites is cell cycle specific
4. Discussion
Acknowledgements
References




*Corresponding author. Tel.: +1 406 9944705; fax: +1 406 9944303; e-mail: uvsmw@gemini.oscs.montana.edu


 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2009 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.